Tennessee recently enacted a minimal expansion of its medical marijuana law. The law took effect May 27, 2021, and it slightly enlarges the medical conditions for which persons may possess a very limited amount of tetrahydrocannabinol (THC). Previously, Tennessee law allowed only those diagnosed with intractable seizures or epilepsy to possess a limited amount of medical cannabis oil. The law also creates a commission to study the possibility of future medical marijuana legalization.
The new measure allows individuals who have the following medical conditions to possess CBD oil containing less than 0.9% of THC:
- Alzheimer’s disease.
- Amyotrophic lateral sclerosis (ALS).
- Cancer, when such disease is diagnosed as end-stage or the treatment produces related wasting illness, nausea and vomiting, or pain.
- Inflammatory bowel disease, including Crohn’s disease and ulcerative colitis.
- Epilepsy or seizures.
- Multiple sclerosis.
- Parkinson’s disease.
- Human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS).
- Sickle cell disease.